<p>/PRNewswire/ -- Collaborative Drug Discovery (CDD)，制药和生物技术行业领先的数据管理解决方案提供商，今天宣布与礼来公司（Eli Lilly and Company）达成协议，将礼来 TuneLab 这一协作式 AI/ML 药物发现平台整合到 CDD Vault 中。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983026/Collaborative_Drug_Discovery_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="400" height="197" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983026/Collaborative_Drug_Discovery_Logo.jpg"/></p>
<p>礼来 TuneLab 是由礼来创建的，旨在通过使参与公司能够访问基于礼来数十年的专有研究数据训练的模型，从而加速生物技术创新。通过这项协议，使用 CDD Vault 的生物技术公司将能够在其自然科学工作流程中利用选定的礼来预测模型。</p>
<p>&#34;通过将 TuneLab 直接整合到 CDD Vault 中，我们正在推进 CDD 的核心愿景，以促进药物发现团队和组织之间的协作。我们相信，解决药物发现中最复杂的挑战将依赖于创新的协作模型，这些模型提供广泛的研究数据访问，并使化学家和生物学家能够做出基于数据的明智决策，&#34; CDD 首席执行官兼总裁 Barry A. Bunin 说。&#34;TuneLab 的 ADMET 模型将适应我们可信的安全 CDD Vault 软件环境，融入实验和计算科学家的自然工作流程，以及我们不断壮大的 CDD Vault 生物制药公司生态系统。&#34;</p>
<p>这项协议为计划在 CDD Vault 中整合礼来 TuneLab 的核心模块和 AI 模块铺平了道路，供选择参与该项目的生物技术公司使用。它建立在 CDD 自 2004 年成立以来的愿景之上：展示基于网络的协作的效率经济。</p>
<p>&#34;TuneLab 的模型与我们的创新相辅相成，例如零点击模型、生成性生物等效物，以及与 SureChEMBL 的超快速深度学习相似性，以便于新颖性和 Enamine 库的便利 SAR-by-catalog，&#34; CDD 研究信息学高级科学家 Dr. Peter Gedeck 分享道。</p>
<p><strong>关于 Collaborative Drug Discovery, Inc.</strong> CDD 的旗舰产品 CDD Vault® 是一个用于安全管理和共享生物和化学研究数据的高级托管数据库解决方案。CDD Vault 提供化学和生物注册管理、结构 - 活性关系（SAR）和实验组织的工具。该平台的可用模块包括注册、活动与可视化、测定、电子实验室笔记本、库存、曲线、人工智能和自动化。<strong>www.collaborativedrug.com</strong></p>
<p><strong>媒体联系人：</strong></p>
<p>Janice Darlington</p>
<p>619-393-2220</p>
<p>jdarlington@collaborativedrug.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983027/Collaborative_Drug_Discovery_Partners_with_Lilly_TuneLab.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="400" height="145" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983027/Collaborative_Drug_Discovery_Partners_with_Lilly_TuneLab.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://edge.prnewswire.com/c/img/favicon.png/query-c2Q9MjAyNi0wNS0yMCZzbj1TRjYyODMy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="16" height="16" original-src="https://imageproxy.pbkrs.com/https://edge.prnewswire.com/c/img/favicon.png/query-c2Q9MjAyNi0wNS0yMCZzbj1TRjYyODMy"/></p>
<p>查看原始内容以下载多媒体：https://www.prnewswire.com/news-releases/collaborative-drug-discovery-partners-with-lilly-tunelab-to-make-lilly-aiml-models-available-in-cdd-vault-302777087.html</p>
<p>来源：Collaborative Drug Discovery, Inc.</p>

礼来

2 倍做多 LLY ETF - Defiance

标普生物技术 3 倍做多 - Direxion

标普生物技术 3 倍做空 - Direxion

2 倍做多 LLY ETF - Direxion

1 倍做空 LLY ETF - Direxion

LLYZ

<p>Collaborative Drug Discovery (CDD) 与礼来（Eli Lilly）合作，将礼来 TuneLab 这一人工智能/机器学习药物发现平台整合到 CDD Vault 中。这一合作使得使用 CDD Vault 的生物技术公司能够访问礼来的预测模型，从而增强药物发现中的数据驱动决策。CDD 的首席执行官 Barry A. Bunin 强调了在应对该领域复杂挑战时合作的重要性。此次整合旨在简化科学家的工作流程，并支持 CDD 高效的基于网络的协作愿景</p>

<p>, /PRNewswire/ -- Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Collaborative Drug Discovery (CDD)，制药和生物技术行业领先的数据管理解决方案提供商，今天宣布与礼来公司（Eli Lilly and Company）达成协议，将礼来 TuneLab 这一协作式 AI/ML 药物发现平台整合到 CDD Vault 中。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983026/Collaborative_Drug_Discovery_Logo.jpg" alt="" original-src="https://mma.prnewswire.com/media/2983026/Collaborative_Drug_Discovery_Logo.jpg"/></p>
<p>Lilly TuneLab was created by Lilly to accelerate biotech innovation by enabling participating companies to access models trained on decades of Lilly's proprietary research data. Through this agreement, biotech companies that use CDD Vault will be able to utilize select Lilly predictive models within their natural scientific workflows.</p>
<div class="lb-trans"><p>礼来 TuneLab 是由礼来创建的，旨在通过使参与公司能够访问基于礼来数十年的专有研究数据训练的模型，从而加速生物技术创新。通过这项协议，使用 CDD Vault 的生物技术公司将能够在其自然科学工作流程中利用选定的礼来预测模型。</p>
</div><p>&#34;By integrating TuneLab directly into CDD Vault, we are advancing CDD's core vision to enable collaboration across drug discovery teams and organizations. We believe that solving the most complex challenges in drug discovery will depend on innovative collaboration models that provide broad access to research data and empower chemists and biologists to make informed, data-driven decisions,&#34; said Barry A. Bunin, CDD Chief Executive Officer and President. &#34;TuneLab's ADMET models will fit in our trusted secure CDD Vault software environment in natural workflows for experimental and computational scientists and with our growing CDD Vault ecosystem of biopharmaceutical companies.&#34;</p>
<div class="lb-trans"><p>&#34;通过将 TuneLab 直接整合到 CDD Vault 中，我们正在推进 CDD 的核心愿景，以促进药物发现团队和组织之间的协作。我们相信，解决药物发现中最复杂的挑战将依赖于创新的协作模型，这些模型提供广泛的研究数据访问，并使化学家和生物学家能够做出基于数据的明智决策，&#34; CDD 首席执行官兼总裁 Barry A. Bunin 说。&#34;TuneLab 的 ADMET 模型将适应我们可信的安全 CDD Vault 软件环境，融入实验和计算科学家的自然工作流程，以及我们不断壮大的 CDD Vault 生物制药公司生态系统。&#34;</p>
</div><p>This agreement paves the way for the planned integration of Lilly TuneLab in both the core and AI modules within CDD Vault for biotech companies that opt in to the program. It builds on CDD's founding vision from 2004: to demonstrate the economics of efficiency of web-based collaboration.</p>
<div class="lb-trans"><p>这项协议为计划在 CDD Vault 中整合礼来 TuneLab 的核心模块和 AI 模块铺平了道路，供选择参与该项目的生物技术公司使用。它建立在 CDD 自 2004 年成立以来的愿景之上：展示基于网络的协作的效率经济。</p>
</div><p>&#34;TuneLab's models are synergistic with our innovations such as Zero Click Models, Generative Bioisosteres, as well as Ultrafast Deep Learning similarity to SureChEMBL for novelty and Enamine libraries for convenient SAR-by-catalog,&#34; shared CDD Research Informatics Senior Scientist Dr. Peter Gedeck.</p>
<div class="lb-trans"><p>&#34;TuneLab 的模型与我们的创新相辅相成，例如零点击模型、生成性生物等效物，以及与 SureChEMBL 的超快速深度学习相似性，以便于新颖性和 Enamine 库的便利 SAR-by-catalog，&#34; CDD 研究信息学高级科学家 Dr. Peter Gedeck 分享道。</p>
</div><p><strong>About Collaborative Drug Discovery, Inc.</strong> CDD's flagship product, CDD Vault®, is a premier hosted database solution for the secure management and sharing of biological and chemical research data. CDD Vault provides tools for chemical and biological registration management, structure-activity relationships (SAR), and experiment organization. The platform's available modules include Registration, Activity &amp; Visualization, Assays, ELN, Inventory, Curves, AI, and Automation. <strong>www.collaborativedrug.com</strong></p>
<div class="lb-trans"><p><strong>关于 Collaborative Drug Discovery, Inc.</strong> CDD 的旗舰产品 CDD Vault® 是一个用于安全管理和共享生物和化学研究数据的高级托管数据库解决方案。CDD Vault 提供化学和生物注册管理、结构 - 活性关系（SAR）和实验组织的工具。该平台的可用模块包括注册、活动与可视化、测定、电子实验室笔记本、库存、曲线、人工智能和自动化。<strong>www.collaborativedrug.com</strong></p>
</div><p><strong>Media Contact:</strong></p>
<div class="lb-trans"><p><strong>媒体联系人：</strong></p>
</div><p>Janice Darlington</p>
<div class="lb-trans"><p>Janice Darlington</p>
</div><p>619-393-2220</p>
<div class="lb-trans"><p>619-393-2220</p>
</div><p>jdarlington@collaborativedrug.com</p>
<div class="lb-trans"><p>jdarlington@collaborativedrug.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2983027/Collaborative_Drug_Discovery_Partners_with_Lilly_TuneLab.jpg" alt="" original-src="https://mma.prnewswire.com/media/2983027/Collaborative_Drug_Discovery_Partners_with_Lilly_TuneLab.jpg"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://edge.prnewswire.com/c/img/favicon.png/query-c2Q9MjAyNi0wNS0yMCZzbj1TRjYyODMy" alt="" original-src="https://edge.prnewswire.com/c/img/favicon.png?sn=SF62832&amp;sd=2026-05-20"/></p>
<p>View original content to download multimedia:https://www.prnewswire.com/news-releases/collaborative-drug-discovery-partners-with-lilly-tunelab-to-make-lilly-aiml-models-available-in-cdd-vault-302777087.html</p>
<div class="lb-trans"><p>查看原始内容以下载多媒体：https://www.prnewswire.com/news-releases/collaborative-drug-discovery-partners-with-lilly-tunelab-to-make-lilly-aiml-models-available-in-cdd-vault-302777087.html</p>
</div><p>SOURCE Collaborative Drug Discovery, Inc.</p>
<div class="lb-trans"><p>来源：Collaborative Drug Discovery, Inc.</p>
</div>

Collaborative Drug Discovery 与礼来 TuneLab 合作，将礼来的 AI/ML 模型整合到 CDD Vault 中